Study of socio-demographic factors in cases of pregnancy induced hypertension and its associated risk factors in a tertiary care hospital

Authors

  • Radheshyam Bairwa Department of Obstetrics and Gynecology, Jhalawar Medical College, Rajasthan, India
  • Shikha Mandve Department of Obstetrics and Gynecology, Jhalawar Medical College, Rajasthan, India
  • Savitri Sharma Department of Obstetrics and Gynecology, Jhalawar Medical College, Rajasthan, India

DOI:

https://doi.org/10.18203/2320-1770.ijrcog20201503

Keywords:

Eclampsia, Gestational age, Pregnancy induced hypertension, Primigravida

Abstract

Background: The aim of the study was to study the socio-demographic factors in cases of pregnancy induced hypertension and its associated risk factors in a tertiary care hospital.

Methods: The present retrospective study was conducted in the obstetrics and gynecology department of Shrimati Heera Kunwar Baa Memorial Hospital, Jhalawar, Rajasthan from December 2018 to November 2019. A total of 80 cases of pregnant women with PIH were studied. The socio-demographic data like age, parity, gestational age of presentation, mode of delivery, maternal and perinatal complications were noted from the hospital records and studied.

Results: The incidence of PIH was found to be 8.16% in pregnant women attending the SHKBM Hospital. Majority of the study subjects were rural dweller (70%). A higher incidence of PIH was found among illiterate women (51.25%). 53.75% cases were in the age group of 25-30 years and 25% were in the age group of 19-24 years. In the present study, incidence of PIH was found to be highest among primigravidas (67.50%) as compared to multigravidas (32.5%). Most cases were delivered by caesarean section (73.75%) and 26.25% were delivered vaginally. Out of 80 cases, 16.25% of cases were complicated by eclampsia, Severe PIH in 12.5%, abruptio placentae in 2.5% and HELLP Syndrome in 1.25% cases.

Conclusions: PIH is a very common complication encountered in pregnancy associated with adverse maternal and fetal outcome. The risk is higher among young primigravidas and in rural population. Better health care facilities and awareness among the pregnant women will help in reducing the incidence of PIH and its associated complications.

References

Dunn P. Major ethical problems confronting perinatal care around the world. Int J Gynaecol Obstet. 1995;5:205-10.

New York State Department of Health. Hypertensive disorders in pregnancy: guideline summary, 2013. Available at: https://www.health.ny.gov/hypertensive disorders/2013_hdp_guideline. Accessed 12 July 2016.

Krishnachetty B, Plaat F. Management of hypertensive disorders of pregnancy. Anaest Tut Week. 2014;304:1-13.

Sibai BM. Diagnosis and management of gestational hypertension and preeclampsia. Obst Gyn. 2003;102(1):181-92.

Sibai BM, Cunningham FG. Prevention of preeclampsia and eclampsia. In Lindheimer MD, Roberts JM, Cunningham FG editors; Chesley’s Hypertensive Disorders of Pregnancy. 3rd edition, Elsevier, New York; 2009:215.

Douglas KA, Redman CWG; Eclampsia in the United Kingdom. Br Med J. 1994;309:1395-400.

World Health Organization; International collaborative study of hypertensive disorders of pregnancy. Geographic variation in the incidence of hypertension in pregnancy. Am J Obstet Gynecol. 1988;158(1):80-3.

Crowther CA. Eclampsia at Harare maternity hospital. An epidemiological study. S Afr Med. 1985;68(13):927-9.

Bergstrom S, Povey G, Songane F, Ching C; Seasonal incidence of eclampsia and its relationship to metereological data in Mozambique. J Perinat Med. 1992;20(2):153-8.

Dutta DC; Text book of obstetrics. 3rd edition, New Central Book Agency (Pvt) Ltd., Calcutta; 1995:230-236.

ACOG; Diagnosis and Management of Preeclampsia and Eclampsia. ACOG Practice Bulletin, No 33; 2002.

World Health Organization, 1998. The World health report: 1998: Life in the 21st century: a vision for all: executive summary (No. WHO/WHR/98.1). Geneva: World Health Organization.

Parmar MT, Solanki HM, Gosalia VV. Study of risk factors of perinatal death in pregnancy induced hypertension (PIH). Nat J Com Med. 2012;3(4):703-7.

Chesley LC, Annitto JE, Cosgrove RA. The familial factor in toxemia of pregnancy. Obstet Gynecol. 1968;32(3):303.

Report of the National high blood pressure education program working group on high blood pressure in pregnancy. Am J Obstet Gynecol. 2000;183(1):S1-S22.

American Society of Nephrology; News release, 2008. Available at: http://www.wrongdiagnosis.com/hd/news/62113 8.pregnant-rural-womenmore-at-risk.htm. Accessed on 13th February 2020.

Sachdeva PD, Patel BG, Bhatt MV. A study of incidence and management of pregnancy induced hypertension in Central Gujarat, India. Inter J Univer Pharma Life Sci. 2011;1(3):61-70.

Saxena S, Srivastava PC, Thimmaraju KV, Mallick AK, Dalmia K, Das B. Socio-demographic profile of pregnancy induced hypertension in a tertiary care centre. Religion. 2014;47(67.14):51.

Jena P, Mohapatra S. A retrospective study of socio-demographic factors in pregnancy induced hypertension in a tertiary care hospital in eastern India. Inter J Clin Obstet Gynaecol. 2019;3(1):78-81.

Umegbolu EI, Ogamba JO. Incidence of gestational hypertension among pregnant women (2006-2015) in Enugu State, Southeast Nigeria: a retrospective study. Inter J Comm Med Pub Health. 2017;4(2):357.

Irinyenikan TA, Olumuyiwa Adebola Roberts OA, Arowojolu A. Serum lipid levels in pregnant normotensive and gestational hypertensive women in Ibadan, Nigeria. Ann Biol Res. 2013;4(4):204-8.

Sandhya S, Bhat BV, Badhe BA. Effect of pregnancy induced hypertension on mothers and their babies. Ind J Pediatr. 2007;74(7):27-9.

Bansal D, Deodhar P. A clinical study of maternal and perinatal outcome in oligohydramnios. J Res Med Den Sci. 2015;3(4):312-6.

Downloads

Published

2020-04-28

Issue

Section

Original Research Articles